Pharmerica (PMC) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/10/2026
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices jump after Trump threatens to hit Iran 'very hard'
- Oracle reports earnings today: Analysts say this metric could 'catalyze higher multiples'
- UBS sees generational semiconductor boom, highlights stock winners
- Hut 8 Mining Corp. (HUT) PT Raised to $55 at KBW As Management Delivers
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Micron to deliver 'another strong quarter', Goldman says
- Supermicro plans $7 billion financing to fund AI server orders
- UK's Ofcom requires tech firms to create crisis response plans
PharMerica Reports Second Quarter 2016 Results
August 9, 2016 8:02 AM EDTDiversified Pharmacy Businesses Exceeding Managements Expectations
Reaffirms Annual 2016 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the second quarter ended June 30, 2016.
     2Q16 Results ÂComparison to
2Q15
ÂComparison to
1Q16
 Revenue   $519.6 million  Increase of 4.4%  Decrease of 0.9%  Gross profit   $81.8 million  Increase of 0.7%  Decrease of 0.2%  ... MorePharMerica Corporation Announces Planned Retirement of Chief Financial Officer David W. Froesel, Jr.
August 9, 2016 8:02 AM EDTSearch Process Underway to Identify Successor
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that David W. Froesel Jr., Executive Vice President, Chief Financial Officer and Treasurer, intends to retire from the Company. Mr. Froesel will continue as Chief Financial Officer through the end of September 2016 to ensure a seamless transition. PharMerica... More
